CAS 1637771-14-2

Alobresib

CAS: 1637771-14-2

Alobresib

Reinheit: ≥95%

Molekulargewicht: 437.49g/mol

Ref: 54-BUP05583

Alobresib

CAS: 1637771-14-2

Alobresib (Vorolanib) is an inhibitor of BET bromodomain,is an antineoplastic drug candidate.

Formel: C₂₆H₂₃N₅O₂

Reinheit: 97.63%

Farbe und Form: Solid

Molekulargewicht: 437.49

Ref: TM-T8495

Alobresib (GS-5829)

CAS: 1637771-14-2

Alobresib is a lysine-specific inhibitor of the bromodomain and extra-terminal domain (BET) family. Alobresib has been shown to selectively inhibit H3K27me3 binding to the BET family of proteins, which may be an important event in cancer development. Alobresib also has the potential to be repositioned as an antineoplastic drug that can be used for the treatment of cancer, such as leukemia, lymphoma, and myeloid leukemia.

Formel: C₂₆H₂₃N₅O₂

Reinheit: Min. 95%

Molekulargewicht: 437.5 g/mol

Ref: 3D-MQC77114